Atovaquone Suspension
Product Images NDC 65162-693

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 65162-693). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Atovaquone Oral Suspension 1)

FDA Label Image

Carton (Atovaquone Oral Suspension 2)

This is a description for a medication called Atovaquone Oral Suspension. The packaging comes in a 210mL container with a dosage of 750mg/5mL. The packaging insert provides information on dosage and administration. The suspension should not be frozen and must be dispensed in a tight container. The medication contains no more than 0.27% v/v of alcohol. The medicine should be stored at 15-25°C and should be shaken gently before using. The drug is distributed by Amneal Pharmaceuticals LLC, based in Bridgewater, NJ.*

FDA Label Image

Label (Atovaquone Oral Suspension 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.